OPEN END TURBO OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000JN3LAW8

Real-time Bid/Ask 01:05:51 27/06/2024 pm IST
2.71 EUR / 2.72 EUR -0.55% Intraday chart for OPEN END TURBO OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+14.23%
1 month+16.17%
Date Price Change
26/24/26 2.73 +1.11%
25/24/25 2.7 +1.50%
24/24/24 2.66 -3.62%
21/24/21 2.76 +4.55%
20/24/20 2.64 -2.58%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 09:16 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer J.P. Morgan
WKN JN3LAW
ISINDE000JN3LAW8
Date issued 16/07/2021
Strike 62.91
Maturity Unlimited
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.93
Lowest since issue 0.086
Spread 0.01
Spread %0.37%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus